Genetic variation in IL28B and spontaneous clearance of hepatitis C virus DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ... Nature 461 (7265), 798-801, 2009 | 2706 | 2009 |
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ... Science 305 (5685), 872-874, 2004 | 1465 | 2004 |
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) CL Thio, EC Seaberg, R Skolasky, J Phair, B Visscher, A Muñoz, ... The Lancet 360 (9349), 1921-1926, 2002 | 1442 | 2002 |
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa CJ Hoffmann, CL Thio The Lancet infectious diseases 7 (6), 402-409, 2007 | 425 | 2007 |
Hepatitis B and human immunodeficiency virus coinfection CL Thio Hepatology 49 (S5), S138-S145, 2009 | 406 | 2009 |
The HBV drug entecavir—effects on HIV-1 replication and resistance MA McMahon, BL Jilek, TP Brennan, L Shen, Y Zhou, M Wind-Rotolo, ... New England Journal of Medicine 356 (25), 2614-2621, 2007 | 368 | 2007 |
Electrode contacts on ferroelectric Pb (ZrxTi1− x) O3 and SrBi2Ta2O9 thin films and their influence on fatigue properties JJ Lee, CL Thio, SB Desu Journal of applied physics 78 (8), 5073-5078, 1995 | 335 | 1995 |
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV International Panel V Soriano, M Puoti, M Bonacini, G Brook, A Cargnel, J Rockstroh, C Thio, ... Aids 19 (3), 221-240, 2005 | 313 | 2005 |
IL28B and the control of hepatitis C virus infection A Balagopal, DL Thomas, CL Thio Gastroenterology 139 (6), 1865-1876, 2010 | 287 | 2010 |
Liver disease in the HIV–infected individual JC Price, CL Thio Clinical Gastroenterology and Hepatology 8 (12), 1002-1012, 2010 | 254 | 2010 |
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013 | 248 | 2013 |
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection CL Thio, DL Thomas, P Karacki, X Gao, D Marti, RA Kaslow, JJ Goedert, ... Journal of Virology 77 (22), 12083-12087, 2003 | 246 | 2003 |
HLA-Cw*04 and Hepatitis C Virus Persistence CL Thio, X Gao, JJ Goedert, D Vlahov, KE Nelson, MW Hilgartner, ... Journal of virology 76 (10), 4792-4797, 2002 | 237 | 2002 |
Racial differences in HLA class II associations with hepatitis C virus outcomes CL Thio, DL Thomas, JJ Goedert, D Vlahov, KE Nelson, MW Hilgartner, ... The Journal of infectious diseases 184 (1), 16-21, 2001 | 237 | 2001 |
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy GV Matthews, A Bartholomeusz, S Locarnini, A Ayres, J Sasaduesz, ... Aids 20 (6), 863-870, 2006 | 227 | 2006 |
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment CL Thio Seminars in liver disease 23 (02), 125-136, 2003 | 218 | 2003 |
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals CL Thio, KR Nolt, J Astemborski, D Vlahov, KE Nelson, DL Thomas Journal of clinical microbiology 38 (2), 575-577, 2000 | 218 | 2000 |
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B CJ Hoffmann, S Charalambous, CL Thio, DJ Martin, L Pemba, KL Fielding, ... Aids 21 (10), 1301-1308, 2007 | 211 | 2007 |
Class II HLA alleles and hepatitis B virus persistence in African Americans CL Thio, M Carrington, D Marti, SJ O'Brien, D Vlahov, KE Nelson, ... The Journal of infectious diseases 179 (4), 1004-1006, 1999 | 189 | 1999 |
Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984–2011 MD Witt, EC Seaberg, A Darilay, S Young, S Badri, CR Rinaldo, ... Clinical infectious diseases 57 (1), 77-84, 2013 | 185 | 2013 |